In-Silico Molecular Modeling Studies to Identify Novel Potential Inhibitors of HPV E6 Protein

The etiological agent of some anogenital tract cancers is infection with the high-risk human papillomavirus (HPV). Currently, prophylactic vaccines against HPV have been validated, but the presence of drug treatment directed against the infection and its oncogenic effects remain essential. Among the...

Full description

Bibliographic Details
Main Authors: Moujane Soumia, Halima Hajji, Mohamed El Mzibri, Filali Zegzouti Younes, Bouachrine Mohammed, Benlyas Mohamed, Moualij Benaissa
Format: Article
Language:English
Published: MDPI AG 2022-09-01
Series:Vaccines
Subjects:
Online Access:https://www.mdpi.com/2076-393X/10/9/1452
_version_ 1797481622404071424
author Moujane Soumia
Halima Hajji
Mohamed El Mzibri
Filali Zegzouti Younes
Bouachrine Mohammed
Benlyas Mohamed
Moualij Benaissa
author_facet Moujane Soumia
Halima Hajji
Mohamed El Mzibri
Filali Zegzouti Younes
Bouachrine Mohammed
Benlyas Mohamed
Moualij Benaissa
author_sort Moujane Soumia
collection DOAJ
description The etiological agent of some anogenital tract cancers is infection with the high-risk human papillomavirus (HPV). Currently, prophylactic vaccines against HPV have been validated, but the presence of drug treatment directed against the infection and its oncogenic effects remain essential. Among the best drug targets, viral oncoprotein E6 has been identified as a key factor in cell immortalization and tumor progression in HPV-positive cells. E6, through interaction with the cellular ubiquitin ligase E6AP, can promote the degradation of p53, a tumor suppressor protein. Therefore, suppression of the creation of the E6-E6AP complex is one of the essential strategies to inhibit the survival and proliferation of infected cells. In the present study, we proposed an in-silico approach for the discovery of small molecules with inhibitory activity on the E6-E6AP interaction. The first three compounds (F0679-0355, F33774-0275, and F3345-0326) were selected on the basis of virtual screening and prediction of the molecules’ ADMET properties and docking with E6 protein, these molecules were selected for further study by investigating their stability in the E6 complex and their inhibitory effect on the E6-E6AP interaction by molecular dynamics (MD) simulation. The identified molecules thus represent a good starting point for the development of anti-HPV drugs.
first_indexed 2024-03-09T22:17:12Z
format Article
id doaj.art-5945eed73ea54c5f814c17c8cb2c6866
institution Directory Open Access Journal
issn 2076-393X
language English
last_indexed 2024-03-09T22:17:12Z
publishDate 2022-09-01
publisher MDPI AG
record_format Article
series Vaccines
spelling doaj.art-5945eed73ea54c5f814c17c8cb2c68662023-11-23T19:21:23ZengMDPI AGVaccines2076-393X2022-09-01109145210.3390/vaccines10091452In-Silico Molecular Modeling Studies to Identify Novel Potential Inhibitors of HPV E6 ProteinMoujane Soumia0Halima Hajji1Mohamed El Mzibri2Filali Zegzouti Younes3Bouachrine Mohammed4Benlyas Mohamed5Moualij Benaissa6Biochemistry of Natural Substances, Faculty of Science and Techniques, Moulay Ismail University, Errachdia 50003, MoroccoMolecular Chemistry and Natural Substances Laboratory, Faculty of Science, Moulay Ismail University, Meknes 52202, MoroccoBiology and Medical Research Unit, National Centre for Energy, Nuclear Sciences and Techniques (CNESTEN), Rabat 10001, MoroccoLABASE Laboratory, Faculty of Science of Meknes, Moulay Ismail University, Meknes 52202, MoroccoMolecular Chemistry and Natural Substances Laboratory, Faculty of Science, Moulay Ismail University, Meknes 52202, MoroccoBiochemistry of Natural Substances, Faculty of Science and Techniques, Moulay Ismail University, Errachdia 50003, MoroccoBiochemistry of Natural Substances, Faculty of Science and Techniques, Moulay Ismail University, Errachdia 50003, MoroccoThe etiological agent of some anogenital tract cancers is infection with the high-risk human papillomavirus (HPV). Currently, prophylactic vaccines against HPV have been validated, but the presence of drug treatment directed against the infection and its oncogenic effects remain essential. Among the best drug targets, viral oncoprotein E6 has been identified as a key factor in cell immortalization and tumor progression in HPV-positive cells. E6, through interaction with the cellular ubiquitin ligase E6AP, can promote the degradation of p53, a tumor suppressor protein. Therefore, suppression of the creation of the E6-E6AP complex is one of the essential strategies to inhibit the survival and proliferation of infected cells. In the present study, we proposed an in-silico approach for the discovery of small molecules with inhibitory activity on the E6-E6AP interaction. The first three compounds (F0679-0355, F33774-0275, and F3345-0326) were selected on the basis of virtual screening and prediction of the molecules’ ADMET properties and docking with E6 protein, these molecules were selected for further study by investigating their stability in the E6 complex and their inhibitory effect on the E6-E6AP interaction by molecular dynamics (MD) simulation. The identified molecules thus represent a good starting point for the development of anti-HPV drugs.https://www.mdpi.com/2076-393X/10/9/1452cervical cancerMD simulationsdockingvirtual screeningE6-E6APADMET properties
spellingShingle Moujane Soumia
Halima Hajji
Mohamed El Mzibri
Filali Zegzouti Younes
Bouachrine Mohammed
Benlyas Mohamed
Moualij Benaissa
In-Silico Molecular Modeling Studies to Identify Novel Potential Inhibitors of HPV E6 Protein
Vaccines
cervical cancer
MD simulations
docking
virtual screening
E6-E6AP
ADMET properties
title In-Silico Molecular Modeling Studies to Identify Novel Potential Inhibitors of HPV E6 Protein
title_full In-Silico Molecular Modeling Studies to Identify Novel Potential Inhibitors of HPV E6 Protein
title_fullStr In-Silico Molecular Modeling Studies to Identify Novel Potential Inhibitors of HPV E6 Protein
title_full_unstemmed In-Silico Molecular Modeling Studies to Identify Novel Potential Inhibitors of HPV E6 Protein
title_short In-Silico Molecular Modeling Studies to Identify Novel Potential Inhibitors of HPV E6 Protein
title_sort in silico molecular modeling studies to identify novel potential inhibitors of hpv e6 protein
topic cervical cancer
MD simulations
docking
virtual screening
E6-E6AP
ADMET properties
url https://www.mdpi.com/2076-393X/10/9/1452
work_keys_str_mv AT moujanesoumia insilicomolecularmodelingstudiestoidentifynovelpotentialinhibitorsofhpve6protein
AT halimahajji insilicomolecularmodelingstudiestoidentifynovelpotentialinhibitorsofhpve6protein
AT mohamedelmzibri insilicomolecularmodelingstudiestoidentifynovelpotentialinhibitorsofhpve6protein
AT filalizegzoutiyounes insilicomolecularmodelingstudiestoidentifynovelpotentialinhibitorsofhpve6protein
AT bouachrinemohammed insilicomolecularmodelingstudiestoidentifynovelpotentialinhibitorsofhpve6protein
AT benlyasmohamed insilicomolecularmodelingstudiestoidentifynovelpotentialinhibitorsofhpve6protein
AT moualijbenaissa insilicomolecularmodelingstudiestoidentifynovelpotentialinhibitorsofhpve6protein